Search - tctmd.com

Displaying 201 - 220 of 689

Sort: Relevancy | Date

Presentation TCT 2022

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

Presenter: Horst Sievert

September 17, 2022

Presentation TCT 2022

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

Presenter: Roland Schmieder

September 17, 2022

Presentation TCT 2022

TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study

Presenter: Daniel Burkhoff

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Presentation TCT 2021

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2021

Update On The Latest Clinical Evidence

Presenter: Ajay Kirtane

November 06, 2021

Presentation TCT 2021

Get To Know Ultrasound RDN (uRDN)

Presenter: Chandan Devireddy

November 06, 2021

Presentation TCT 2021

Establishing Consensus: US Guidance Updates

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

Leading with Evidence: Latest Data on Renal Denervation

Presenter: NULL

November 06, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Presenter: Daniel Burkhoff

November 05, 2021

Presentation TCT 2021

Latest Evidence in the SPYRAL-HTN Clinical Program

Presenter: NULL

November 05, 2021

Presentation TCT 2021

TCT 105: Impact of pulmonary hypertension differentiation on the outcome of patients undergoing MitraClip® therapy

Presenter: Tobias Schmidt

November 05, 2021

Presentation TCT 2021

Adequacy of Blood Pressure Control in High-Risk Hypertensive Patients: The DEGREE Study

Presenter: Victor Zeijen

November 04, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Presenter: Daniel Burkhoff

November 04, 2021

Presentation TCT 2021

Best Practices for the Future Implementation of Interventional Therapies for Hypertension

Presenter: Michael Bloch

November 04, 2021

Presentation TCT 2021

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Presenter: Herbert D. Aronow

November 04, 2021

Presentation TCT 2021

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

Presenter: Daniel Burkhoff

November 04, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

Presentation TCT 2021

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Presenter: Michael A. Weber

November 04, 2021

Presentation TCT 2021

Dietary and Pharmacologic Approaches to Hypertension Management in 2021 – What’s New and What’s Changed

Presenter: Debbie Cohen

November 04, 2021

Advertisement

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Update On The Latest Clinical Evidence

Get To Know Ultrasound RDN (uRDN)

Establishing Consensus: US Guidance Updates

Leading with Evidence: Latest Data on Renal Denervation

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Latest Evidence in the SPYRAL-HTN Clinical Program

TCT 105: Impact of pulmonary hypertension differentiation on the outcome of patients undergoing MitraClip® therapy

Adequacy of Blood Pressure Control in High-Risk Hypertensive Patients: The DEGREE Study

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Best Practices for the Future Implementation of Interventional Therapies for Hypertension

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication!

Pacemaker-Mediated Baroreflex Stimulation: New Clinical Data and Further Follow-up

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Dietary and Pharmacologic Approaches to Hypertension Management in 2021 – What’s New and What’s Changed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content